Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Microsoft Corporation (MSFT), Nokia Corporation (ADR) (NOK), LinkedIn Corp (LNKD): This Week’s Dumbest Stock Moves

Page 1 of 2

Stupidity is contagious. It gets us all from time to time. Even respectable companies can catch it. As I do every week, let’s take a look at five dumb financial events this week that may make your head spin.

1. There will be blood

“I’m finished,” are the final lines of Daniel Day Lewis’ ruthless Daniel Plainview character in There Will Be Blood, and now Microsoft Corporation (NASDAQ:MSFT) is saying that it’s Finnish. The software giant struck a roughly $7.2 billion deal to buy Nokia Corporation (ADR) (NYSE:NOK)‘s devices and services business.

It’s been speculated that Nokia Corporation (ADR) (NYSE:NOK) had finally seen the light, realizing that it was a trap to accept Microsoft Corporation (NASDAQ:MSFT)’s money to back the fledgling platform in the first place, and gearing to move on to the Android standard. Microsoft’s Windows Phone would’ve been toast.

LinkedIn Corp (NYSE:LNKD)

However, buying a hardware company essentially does the same thing. Samsung and HTC will likely abandon the halfhearted support that they were showing Windows. It will be all on Nokia Corporation (ADR) (NYSE:NOK) now, and that’s probably not a good wager.

Yes, Android’s parent did the same thing when it snapped up Motorola’s handset business, but it was the open source platform of choice. No one was going to turn its back on that money tree. It will be easy to do that to Microsoft Corporation (NASDAQ:MSFT) now.

2. Come back to the penalty box, Mr. Softy

We can’t let Microsoft Corporation (NASDAQ:MSFT) get off that easily. Let’s also talk about announcing Nov. 22 as the availability for the Xbox One. There’s plenty riding on its new gaming console, and the $500 price tag — $100 more than the PS4 and $200 more than the recently reduced price of the deluxe Wii U — leaves little margin for error.

Yes, it’s great that Microsoft Corporation (NASDAQ:MSFT) is putting out its machine a week before Black Friday. You certainly don’t want to hit the market after the shopping holiday season begins. However, the PS4 is coming out on Nov. 15. What can Microsoft gain by coming out a week after its rival?

Sure, the plan will work if the PS4 is scarce or critically panned, but wouldn’t the same thing happen if Microsoft had put its machine out a week or two before the PS4? There are no bragging rights in being the last console to hit the market, especially if you’re also the most expensive.

3. This won’t look good on your resume

LinkedIn Corp (NYSE:LNKD) didn’t need the money, but it still went ahead with a secondary offering. Yes, it raised $1.2 billion by selling nearly 5.4 million shares, but there’s something wrong about announcing a secondary when your stock is at $246.13, and then pricing the freshly minted shares at $223.

The difference — in market cap — is $2.6 billion, or more than double the amount that was ultimately raised.

However, what really has to leave you scratching your head is how the shares bounced back to hit an all-time high on Thursday. Isn’t an unnecessary secondary offering after a strong rally an implication that the board feels that the shares are priced dearly?

4. YuMe and everyone we know

YuMe Inc (NYSE:YUME) was shown some analyst love this week, but it’s largely irrelevant. Sure, shares of the online advertising company initially moved higher on news that Citi, Piper Jaffray, Needham & Co., and Deutsche Bank all began coverage with buy ratings. However, the important distinction here is that these are the same four companies that took YuMe Inc (NYSE:YUME) public at $9 last month.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!